Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 9/20 | 0.51 |
| ▸ | HTR2C | P28335 | 8/20 | 0.51 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.41 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.41 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.41 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.41 |
| ▸ | PRKAG3 | Q9UGI9 | 1/20 | 0.41 |
| ▸ | PRKAG2 | Q9UGJ0 | 1/20 | 0.41 |
| ▸ | PRKAB1 | Q9Y478 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | SYK | P43405 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1166761 | 0.84 | HTR2A (0.64) | HTR2AHTR2CPRKAB2PRKAG1PRKAA2 | |
| SCHEMBL4768514 | 0.83 | HTR2A (0.49) | HTR2AHTR2CPRKAB2PRKAG1PRKAA2 | |
| SCHEMBL1166025 | 0.81 | HTR2A (0.60) | HTR2AHTR2CPRKAB2PRKAG1PRKAA2 | |
| SCHEMBL4724119 | 0.81 | HTR2A (0.48) | HTR2AHTR2CPRKAB2PRKAG1PRKAA2 | |
| SCHEMBL4659261 | 0.76 | HTR2A (0.40) | HTR2AHTR2C | |
| SCHEMBL4724168 | 0.75 | HTR2A (0.61) | HTR2AHTR2CMAPT | |
| SCHEMBL22936210 | 0.74 | ALDH1A1 (0.52) | MAPTSIGMAR1 | |
| SCHEMBL4696722 | 0.74 | HTR2A (0.66) | HTR2AHTR2CPOLBMAPT | |
| SCHEMBL1165844 | 0.74 | HTR2A (0.63) | HTR2AHTR2C | |
| SCHEMBL1166100 | 0.73 | HTR2A (0.62) | HTR2AHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2004627-A2 | 3-PYRIDINYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | Arena Pharmaceuticals, Inc. (US) | 2008-12-24 | — | — | EP | disclosed |
| WO-2007120600-A2 | 3-PYRIDINYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. (US) | 2007-10-25 | — | — | WO | disclosed |
| WO-2007120600-A2 | 3-PYRIDINYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. (US) | 2007-10-25 | — | — | WO | disclosed |